FTC Approves Final Order Preserving Competition in the U.S. Markets for Two Types of Medical Testing Devices
Date
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere...